Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Cohen

Showing results (71-80 of 112) with videos related to

Pageof 12
Sort By:
Chest|July 29, 2021
Presentation, Diagnosis, and Management of Subglottic and Tracheal Stenosis During Systemic Inflammatory DiseasesJennifer Catano, Yurdagul Uzunhan, Romain Paule, et al.
The Journal of Rheumatology|May 9, 2008
Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label studyAlice Bérezné, Brigitte Ranque, Dominique Valeyre, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 27, 2015
Brief Report: Childhood-Onset Systemic Necrotizing Vasculitides: Long-Term Data From the French Vasculitis Study Group RegistryMichele Iudici, Xavier Puéchal, Christian Pagnoux, et al.
Rheumatology (Oxford, England)|May 23, 2020
Risk factors for hydroxychloroquine retinopathy in systemic lupus erythematosus: a case-control study with hydroxychloroquine blood-level analysisTiphaine Lenfant, Sawsen Salah, Gaëlle Leroux, et al.
Rheumatology (Oxford, England)|April 19, 2023
Prognostic value of automated assessment of interstitial lung disease on CT in systemic sclerosisAëlle Le Gall, Trieu-Nghi Hoang-Thi, Raphaël Porcher, et al.
JAMA Network Open|November 28, 2022
Rituximab vs Cyclophosphamide Induction Therapy for Patients With Granulomatosis With PolyangiitisXavier Puéchal, Michele Iudici, Elodie Perrodeau, et al.
The New England Journal of Medicine|December 26, 2008
Azathioprine or methotrexate maintenance for ANCA-associated vasculitisChristian Pagnoux, Alfred Mahr, Mohamed A Hamidou, et al.
Seminars in Arthritis and Rheumatism|November 6, 2017
Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, FranceJérôme Avouac, Anna Moltó, Vered Abitbol, et al.
Rheumatology (Oxford, England)|May 7, 2019
Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trialXavier Puéchal, Christian Pagnoux, Gabriel Baron, et al.
Seminars in Arthritis and Rheumatism|September 27, 2021
DADA2 diagnosed in adulthood versus childhood: A comparative study on 306 patients including a systematic literature review and 12 French casesAntoine Fayand, François Chasset, David Boutboul, et al.
Pageof 12

Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Chest|July 29, 2021
Presentation, Diagnosis, and Management of Subglottic and Tracheal Stenosis During Systemic Inflammatory DiseasesJennifer Catano, Yurdagul Uzunhan, Romain Paule, et al.
The Journal of Rheumatology|May 9, 2008
Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label studyAlice Bérezné, Brigitte Ranque, Dominique Valeyre, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 27, 2015
Brief Report: Childhood-Onset Systemic Necrotizing Vasculitides: Long-Term Data From the French Vasculitis Study Group RegistryMichele Iudici, Xavier Puéchal, Christian Pagnoux, et al.
Rheumatology (Oxford, England)|May 23, 2020
Risk factors for hydroxychloroquine retinopathy in systemic lupus erythematosus: a case-control study with hydroxychloroquine blood-level analysisTiphaine Lenfant, Sawsen Salah, Gaëlle Leroux, et al.
Rheumatology (Oxford, England)|April 19, 2023
Prognostic value of automated assessment of interstitial lung disease on CT in systemic sclerosisAëlle Le Gall, Trieu-Nghi Hoang-Thi, Raphaël Porcher, et al.
JAMA Network Open|November 28, 2022
Rituximab vs Cyclophosphamide Induction Therapy for Patients With Granulomatosis With PolyangiitisXavier Puéchal, Michele Iudici, Elodie Perrodeau, et al.
The New England Journal of Medicine|December 26, 2008
Azathioprine or methotrexate maintenance for ANCA-associated vasculitisChristian Pagnoux, Alfred Mahr, Mohamed A Hamidou, et al.
Seminars in Arthritis and Rheumatism|November 6, 2017
Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, FranceJérôme Avouac, Anna Moltó, Vered Abitbol, et al.
Rheumatology (Oxford, England)|May 7, 2019
Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trialXavier Puéchal, Christian Pagnoux, Gabriel Baron, et al.
Seminars in Arthritis and Rheumatism|September 27, 2021
DADA2 diagnosed in adulthood versus childhood: A comparative study on 306 patients including a systematic literature review and 12 French casesAntoine Fayand, François Chasset, David Boutboul, et al.
Pageof 12